CORRESP Filing
Oncology Institute, Inc.
Date: June 16, 2025 · CIK: 0001799191 · Accession: 0001079973-25-001045
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287138, 333-287848
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Re: The Oncology Institute, Inc. Registration Statement on Form S-3, filed June 6, 2025 File No. 333-287138
Dear Mr. Augustin:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, The Oncology Institute, Inc. (the " Company ") hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287848) (the " Registration Statement "), as amended on June 16, 2025. The Company respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on June 18, 2025 or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Steven B. Stokdyk at (213) 891-7421.
Very truly yours,
THE ONCOLOGY INSTITUTE, INC.
Show Raw Text
CORRESP 1 filename1.htm Correspondence THE ONCOLOGY INSTITUTE, INC. 18000 Studebaker Road, Suite 800 Cerritos, CA 90703 June 16, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attn: Robert Augustin Re: The Oncology Institute, Inc. Registration Statement on Form S-3, filed June 6, 2025 File No. 333-287138 Dear Mr. Augustin: In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, The Oncology Institute, Inc. (the " Company ") hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287848) (the " Registration Statement "), as amended on June 16, 2025. The Company respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on June 18, 2025 or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Steven B. Stokdyk at (213) 891-7421. Very truly yours, THE ONCOLOGY INSTITUTE, INC. /s/ Robert Carter Robert Carter Chief Financial Officer cc: Daniel Virnich, The Oncology Institute, Inc. Steven B. Stokdyk, Latham & Watkins LLP Brent T. Epstein, Latham & Watkins LLP